Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 11, 2016
[Pathogenesis and novel therapy for EBV-related B-cell lymphoma]Ai Sato, Natsuko Yamakawa, Ai KotaniInternational Journal of Molecular Sciences|July 12, 2017
miRNAs in Normal and Malignant HematopoiesisRyutaro Kotaki, Ryo Koyama-Nasu, Natsuko Yamakawa, et al.International Journal of Hematology|April 2, 2014
Small RNA as a regulator of hematopoietic development, immune response in infection and tumorigenesisKazuki Okuyama, Jun Ogata, Natsuko Yamakawa, et al.The Journal of Biological Chemistry|October 12, 2012
Structural analyses of human Toll-like receptor 4 polymorphisms D299G and T399IUmeharu Ohto, Natsuko Yamakawa, Sachiko Akashi-Takamura, et al.International Immunology|June 30, 2011
Intracellular TLR4/MD-2 in macrophages senses Gram-negative bacteria and induces a unique set of LPS-dependent genesTakuma Shibata, Yuji Motoi, Natsuko Tanimura, et al.Plos One|January 19, 2012
DNA display selection of peptide ligands for a full-length human G protein-coupled receptor on CHO-K1 cellsNobuhide Doi, Natsuko Yamakawa, Hideaki Matsumoto, et al.Journal of Human Immunity|February 26, 2026
Identification of a novel TLR7 gain-of-function variant that underlies systemic lupus erythematosusAiswarya Sethumadhavan, Charles Mariasoosai, Natsuko Yamakawa, et al.International Immunology|September 11, 2012
Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid ANatsuko Yamakawa, Umeharu Ohto, Sachiko Akashi-Takamura, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2020
Vaccination with Intradermal Bacillus Calmette-Guérin Provides Robust Protection against Extrapulmonary Tuberculosis but Not Pulmonary Infection in Cynomolgus MacaquesYusuke Tsujimura, Yumiko Shiogama, Shogo Soma, et al.Genes to Cells : Devoted to Molecular & Cellular Mechanisms|October 27, 2025
Development of a Novel Mucosal Vaccine Vector Derived From Human Parainfluenza Virus Type 2 and Its Efficacy as a SARS-CoV-2 Vaccine by Intratracheal Administration Using Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2Akira Kawano, Masamitsu N Asaka, Mitsuo Kawano, et al.Pageof 3